固本壮骨胶囊与仙灵密骨颗粒治疗原发性骨质疏松症60例临床观察

目的:观察固本壮骨胶囊与仙灵密骨颗粒两种药物治疗原发性骨质疏松症的临床疗效。方法:将120例原发性骨质疏松症患者随机分为固本壮骨胶囊组和仙灵密骨颗粒组,每组60例。固本壮骨胶囊组给予固本壮骨胶囊治疗,仙灵密骨颗粒组给予仙灵密骨颗粒治疗。结果:固本壮骨胶囊组在改善患者腰膝酸软和头目眩晕症状以及提高病人腰椎(L2-4)骨密度方面明显优于仙灵密骨颗粒组(P0.05)。结论:固本壮骨胶囊与仙灵密骨颗粒都可用于治疗原发性骨质疏松症,固本壮骨胶囊具有更好的疗效。     

壮骨汤治疗原发性骨质疏松症45例临床观察

目的:观察壮骨汤治疗原发性骨质疏松症的临床疗效。方法:将90例原发性骨质疏松症患者随机分为治疗组与对照组各45例,治疗组用壮骨汤治疗,对照组用仙灵骨葆胶囊治疗。观察比较两组治疗3个月后的综合疗效。结果:总有效率治疗组为84.4%,对照组为64.4%,两组综合疗效比较,差异有统计学意义(P<0.05)。结论:壮骨汤治疗原发性骨质疏松症疗效显著。     

温肾壮骨颗粒治疗原发性Ⅰ型骨质疏松症28例

目的观察温肾壮骨颗粒治疗原发性I型骨质疏松症的临床疗效。方法将56例原发性I型骨质疏松症患者随机分为治疗组和对照组各28例。对照组采用钙尔奇D常规治疗,治疗组在对照组基础上加服温肾壮骨颗粒治疗。两组均治疗6个月,6个月后统计疗效。结果治疗组总有效率89.3%,对照组总有效率50.0%,两组比较,差异有统计学意义(P0.05)。结论温肾壮骨颗粒治疗原发性I型骨质疏松症疗效满意。     

益肾壮骨方治疗原发性骨质疏松症疗效观察

目的观察益肾壮骨方治疗原发性骨质疏松的疗效。方法将64例原发性骨质疏松患者随机分为两组,治疗组各34例,采用益肾壮骨方治疗,对照组30例,采用鲑鱼降钙素治疗,并观察两组的疗效及不良反应。结果两组的疾病总有效率分别为82.35%、76.67%,差异无显著性;中医证候疗效治疗组为91.18%、83.33%,治疗组高于对照组,差异有显著性（P〈0.05）。两组治疗后骨密度较治疗前均有上升（P〈0.05）,但对照组股骨颈骨密度治疗后与治疗前比较,差异无显著性（P〉0.05）。结论益肾壮骨方治疗原发性骨质疏松症疗效确切,价格低廉,值得推广。     

壮骨饮治疗原发性骨质疏松症100例疗效观察

目的：探讨自拟壮骨饮治疗原发性骨质疏松症的疗效。方法：将符合纳入标准的原发性骨质疏松症患者100例,随机分为治疗组50例和对照组50例,分别采用自拟壮骨饮与密盖息针联用钙尔奇D治疗,治疗12周后观察治疗前后主要症状的缓解程度、L2-L4腰椎BMD水平、股骨颈BMD水平和血液中钙、磷、碱性磷酸酶检查结果改变,利用SPSS进行统计分析。结果：治疗组总有效率为94%,对照组为64%,两组比较,差异有统计学意义（P〈0.05）;且治疗组的腰椎（L2-L4）、股骨颈BMD有明显提高（P〈0.01）;且治疗组治疗前后ALP指标明显下降,差异有统计学意义（P〈0.05）。结论：自拟壮骨饮是治疗原发性骨质疏松症有效而安全的方剂。     

强筋壮骨丸治疗原发性骨质疏松症疗效观察

目的:观察强筋壮骨丸治疗原发性骨质疏松症的临床疗效。方法:选择原发性骨质疏松症76例,随机分为两组各38例。治疗组采用强筋壮骨丸口服,对照组口服迪巧,6个月为1个疗程。结果:治疗组显效12例,有效22例,无效4例,总有效率为89.47%,对照组显效6例,有效17例,无效15例,总有效率为60.53%,两组疗效比较,差异有统计学意义(P0.01)。结论:强筋壮骨丸治疗原发性骨质疏松症患者疗效较显著。     

壮骨镇痛胶囊治疗原发性骨质疏松症骨痛临床疗效观察

目的:观察壮骨镇痛胶囊治疗原发性骨质疏松症骨的临床疗效。方法:选择40例原发性骨质疏松症骨痛患者,对照组20例应用钙尔奇D治疗,治疗组20例应用壮骨镇痛胶囊治疗,疗程均为2个月。并分别对两组治疗前后疼痛缓解情况(VAS评分)、骨密度指标、有效率、生化指标、用药安全性进行观察分析。结果:治疗组临床疗效明显优于对照组组(P0.05)。结论:壮骨镇痛胶囊能安全有效缓解原发性骨质疏松引发的疼痛。     

温肾壮骨汤治疗原发性骨质疏松症临床观察

目的:探讨温肾壮骨汤在原发性骨质疏松症治疗中的临床效果。方法:选取于2012年9月—2013年11月于我院骨科门诊收治的原发性骨质疏松症患者90例。根据临床给药经验,给予对照组患者鲑鱼降钙素,治疗组患者使用我院自行调配的温肾壮骨汤进行治疗,对比两组患者的治疗效果。结果:治疗组有效率为86.7%,对照组有效率为64.4%,两组患者治疗情况比较,治疗组优于对照组,差异具有统计学意义,P0.05。结论:温肾壮骨汤是一种有效治疗原发性骨质疏松症的临床治疗方案,该方案治疗效果显著,治疗过程中未发现临床不良反应发生,值得广泛推广和深入研究。     

益肾壮骨丸口服治疗原发性骨质疏松症158例

目的:观察益肾壮骨丸口服治疗原发性骨质疏松症的疗效.方法:2009年3月至2012年3月,采用益肾壮骨丸口服治疗原发性骨质疏松症患者158例,男75例,女83例;年龄56 ～78岁,中位数67.5岁;病程6个月至10年,中位数33.5个月.治疗3个疗程后观察患者症状及骨密度改善情况并评定疗效.结果:本组158例,显效83例,好转68例,无效7例;均无不良反应发生.结论:益肾壮骨丸口服治疗原发性骨质疏松症,疗效可靠、安全,但其具体的作用机制还有待进一步研究.     

壮骨通络宝治疗原发性骨质疏松症临床观察

目的：探讨壮骨通络宝对原发性骨质疏松症的临床疗效。方法：将65例原发性骨质疏松症患者,随机分为中药组和西药组,中药组应用壮骨通络宝治疗,西药组应用维生素D：加钙片治疗。结果：中药组有效率92．5％,骨密度（0．79±0．15）g／cm^2,西药组有效率65．0％,骨密度（0．70±0．09）g／cm^2,中药组上述指标均明显的高于西药组。结论：壮骨通络宝治疗原发性骨质疏松疗效确切。     

微波消解-电感耦合等离子体质谱法测定脉络宁注射液中25种矿物质元素

目的建立微波消解-电感耦合等离子体质谱(ICP-MS)直接稀释测定脉络宁注射液中25种矿物质元素(Mg、Ca、Fe、Cu、Zn、Mn、Al、B、Ba、Co、Cr、K、Li、Mo、Na、Ni、P、Pb、Sr、Th、Ti、V、As、Cd和Hg)的方法。方法分别对微波消解条件和测试条件进行考察;样品经微波消解后,采用电感耦合质谱仪测定25种矿物质元素,并对测定方法学进行考察。结果确定最佳消解条件为3步缓慢升温:400 W 80℃升温10 min,保留5 min;600 W 120℃升温10 min,保留5 min;900 W 200℃升温20 min,保留20 min;25种矿物质元素在各自的线性范围内线性关系良好,r≥0.999 6,精密度、稳定性和重复性试验的RSD均符合定量分析要求;加标回收率为94.7%~106.1%,RSD在0.34%~2.79%。脉络宁注射液中检测出Mg、Ca、Fe、Cu、Zn、Mn、Al、B、Ba、Co、Cr、K、Li、Mo、Na、Ni、P、Pb、Sr、Th、Ti、V,未检出As、Cd和Hg。结论该方法简便、迅速、准确,适用于脉络宁注射液中25种矿物质元素的同时测定。     

Die Lateralität und Lateralitätsinstabilität in der Diagnostik und Therapie

The disturbance and instability of laterality are obstacles to diagnostics and therapy. Correction prior to starting therapy is required. They also predispose toward defined health problems and unspecific diseases. Numerous research activities provide evidence of the relevance of undisturbed laterality in diagnostics and therapy. Techniques of testing and therapeutic corrections will allow for optimized therapy success.     

Journal of Acupuncture and Tuina Science Instructions for Authors

The Journal of Acupuncture and Tuina Science, a journal with an international scope （IS SN 1672-3597, CN 31-1908/R, Bimonthly）, is embodied by ＇Springer Verlag＇ Database, Index Copernicus （IC） and Chinese Scientific and Technical Paper and Citations Data （CSTPCD）. You can search full text on http：//www, springerlink, com/content/1672 -3597.     

Yerba Mate or Paraguay Tea

正Beverages based on Ilex paraguariensis A.St.-Hil.are used in the south Brazil and other Latin American countries located at the so-called southern cone.It is known as chimarro or mate in south and southeast Brazil,tererêin     

基于ICP-MS法的加味左金丸中无机元素分析

目的 通过电感耦合等离子体质谱（inductively coupled plasma mass spectrometry,ICP-MS）法建立加味左金丸中Cd、Pb、As、Hg、Co、V、Ni、Cu、Li、Sb、Ba、Mo、Sn、Cr、Na、Mg、Al、Ca、Ti、Mn、Fe、Zn、Ga、Se、Sr、Tl共计26种无机元素的测定方法。方法 加味左金丸通过微波消解法处理后,根据相对分子质量的大小选择内标物,其中⁷Li、²³Na、²⁴Mg、²⁷Al、⁴⁰Ca、⁴⁸Ti、⁵¹V、⁵²Cr、⁵⁵Mn、⁵⁶Fe、⁵⁸Ni、⁵⁹Co、⁶³Cu、⁶⁶Zn、⁷⁰Ga、⁷⁵As、⁷⁷Se、⁸⁶Sr以⁷²Ge作为内标;⁹⁵Mo、¹¹⁴Cd、¹¹⁸Sn、¹²¹Sb、¹³⁷Ba以¹¹⁵In作为内标;²⁰²Hg、²⁰⁵Tl、²⁰⁸Pb以²⁰⁹Bi作为内标。对标准品溶液、空白溶液与供试品溶液进行分析,采用标准曲线法进行定量分析。通过ICP-MS法进行测定。结果 26种无机元素线性的相关系数r ≥ 0.999 6,检出限为0.001~1.500μg/L,定量限为0.01~5.00 μg/L,精密度与重复性试验的RSD均小于5%,平均回收率在82.64%~106.44%,RSD均小于5%。对3个厂家的12批样品进行了测定,26种元素的含量差异较大,其中Na、Mg、Ca、Fe 4种元素的含量比较高,均大于500 μg/g,Cd、Pb、As、Hg、Co、Li、Sb、Mo、Sn、Cr、Se、Tl的含量比较低,均小于1 μg/g。由结果可知,人体的常量元素,如Na、Mg、Ca的含量比较高,Cd、Pb、As、Hg等有害元素含量比较低。根据《中国药典》2020年版一部的要求,本品中Cd、Pb、As、Hg与Cu均符合规定。结论 该方法快速、准确,可以用于加味左金丸中无机元素的测定。     

Ethnopharmacologic study of chinese rhubarb

This paper deals with an interdisciplinary study covering historic, botanical, phytochemical, pharmacological and clinical aspects of rhubarb and related species, to lay stress on the correlation between plant phylogeny, chemical constituents and purgative activity.

It was found that the official rhubarbs were exclusively restricted in the Sect. Palmata e.g. Rheum palmatum R. palmatum var. tanguticum R. officinale; the following criteria may serve as their standard, viz., the presence of sennoside derivatives and rhein, the occurrence of the reduced form of rhein and aloe-emodin, the leaves with any kind of palmate incision. Comprehensive multivariate analyses showed that there is a very close relationship between the leaf incision, existence of sennosides or rhein and purgative activity.     

Erstaunliches Ergebnis einer Schädelakupunktur nach Yamamoto bei Hemihypsarrhythmie rechts

A girl, three and a half years old at the respective date, premature in 25th week of gestation, had been presented. On day three after birth, she had had a IVH III° right and left with severe involvement of parenchyma and other multiple complications, e. a. infant respiratory distress syndrome up to the 42nd day postpartum, and epileptic attacks with apnoeic events.     

Wirksamkeit der Akupunktur bei der Therapie von idiopathischen Schmeckstörungen: Eine randomisierte Placebo-kontrollierte Studie

Background

At present, the state-of-the-art medication in treating idiopathic taste disorder (gustatory dysfunction) is zinc. If zinc medication was unsuccessful, not tolerated or if it is contraindicated the persons affected can hardly be helped.

Objectives

In a randomized placebo-controlled clinical trial an attempt was made to determine the efficacy of acupuncture.

Methods

The treatment group was treated with acupuncture needles, the placebo group with an inactive acupuncture-laser. Endpoints of the study were changes in the taste test, the quality of life and the severity of symptoms of depression (BDI) as well as mood changes (ZMS). Satisfaction with the success of the respective therapy was also evaluated. Data were collected before and after therapy and again for the treatment group 10 weeks after completion of the treatment period.

Findings

Treatment with real acupuncture showed a significant improvement in gustatory function as well as a significant improvement in psychological symptoms. Greater satisfaction with the treatment results was evident in the treatment group. The treatment results of acupuncture remained stable over a period of ten weeks after completion of the treatment.

Conclusion

Acupuncture was effective in the therapy of idiopathic taste disorders and therefore it is an effective alternative when zinc medication is not tolerated or unsuccessful. But it is also suitable as a therapy of first choice. Acupuncture can be considered as an extension of the therapeutic spectrum in the difficult treatment of taste disorders.     

七味红花殊胜散对缺血再灌注肝损伤的保护作用

目的::研究七味红花殊胜敬对缺血再灌注肝损伤的保护作用.方法:在大鼠肝缺血再灌注模型上,观察七味红花殊胜散对缺血再灌注肝损伤引起的血清丙二醛(MDA)、超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、一氧化氮(NO)含量的变化.结果:七味红花殊胜散对大鼠血清MDA、SOD、GSH与再灌组比较有明显差异(P<0.05),NO含量与再灌组比较有明显差异(P<0.05).结论:七味红花殊胜散对大鼠急性缺血再灌注肝损伤具有保护作用.